Allarity Therapeutics, Inc. Price/Book Ratio
The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.
- Allarity Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 5.8, a 378.33% increase year-over-year.
- Allarity Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 2.53, a 195.67% increase year-over-year.
- Allarity Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 1.78, a 145.41% increase year-over-year.
- Allarity Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 2.09, a 365.99% increase year-over-year.
- Allarity Therapeutics, Inc. price/book ratio for fiscal 2026 was 5.8.
- Allarity Therapeutics, Inc. price/book ratio for fiscal 2025 was 1.78, a 145.41% increase from fiscal 2024.
- Allarity Therapeutics, Inc. price/book ratio for fiscal 2024 was 0.72, a change of 1.9 from fiscal 2023.
- Allarity Therapeutics, Inc. price/book ratio for fiscal 2023 was -1.18, a change of 24,817.21 from fiscal 2022.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical Price/Book Ratio
Annual Price/Book Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |